Background
==========

Dying cells may be the source of the autoantigens that initiate and/or perpetuate systemic autoimmunity. C1q-deficient mice develop a lupus-like disease and accumulate apoptotic cells in their kidneys, and our studies \[[@B1]\] suggested that classical complement components facilitate the clearance of apoptotic cells. Mice deficient in serum IgM (sIgM) also develop a lupus-like disease.

Objective
=========

Since IgM binds to apoptotic cells and activates the classical complement on the apoptotic cells *in vitro*\[[@B2]\], we asked whether sIgM was required for complement activation and rapid removal of dying cells by phagocytic cells *in vivo*.

Methods
=======

Apoptotic thymocytes were injected into the peritoneum of mice that had received thioglycollate 3 days previously. Thirty minutes after intraperitoneal injection, apoptotic cell uptake by elicited peritoneal macrophages was determined by light microscopy.

Results
=======

The percentages of peritoneal macrophages that ingested apoptotic cells were (mean ± standard error): wild type (WT) (*n*= 12), 31.2 ± 4.7%; C1q^-/-^(*n*= 4), 9.4 ± 1.8%; sIgM^-/-^(*n*= 16), 8.5 ± 0.9%. The differences between C1q-deficient and WT mice as well as between sIgM deficient and WT mice were highly significant (*P*= 0.0036 and *P*= 0.0003, respectively). Mice heterozygous for sIgM showed an intermediate result (17.9 ± 1.8%). To determine whether the clearance defect in the sIgM-deficient mice could solely be attributed to IgM deficiency, apoptotic thymocytes were preincubated with purified murine IgM prior to intraperitoneal injection into sIgM-deficient mice. IgM completely restored the ability of sIgM-deficient mice to ingest apoptotic cells. Finally, to prove that IgM and C1q function in the same pathway to facilitate clearance of apoptotic cells, we created C1q/IgM double knockout mice. In contrast to the IgM single knockout mice, addition of IgM to the double knockout mice failed to restore phagocytosis of apoptotic cells.

Conclusions
===========

These findings indicate that IgM plays a pivotal role in clearance of apoptotic cells, and that this occurs through activation of the classical pathway of complement. IgM upstream of complement-mediated opsonization of dying cells provides a unifying mechanism explaining why mice with either early complement component or sIgM deficiency develop lupus-like diseases. These findings have important implications for understanding the pathogenesis of lupus in humans.
